Aptose Biosciences Inc.
APTOFNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for APTOF. That does not mean none is planned.
Get an email about APTOF's next catalysts
Track Aptose Biosciences (APTOF) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 0 past
No catalysts found.
Market Overview
Stock performance and key metrics
Virulizin®
Pancreatic Cancer
GTI-2040
Acute Myeloid Leukemia
Tuspetinib
Leukemia, Myeloid, Acute
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Virulizin® | Phase 3 | Pancreatic Cancer | - | - |
GTI-2040 | Phase 2 | Acute Myeloid Leukemia | - | - |
Tuspetinib | Phase 2 | Leukemia, Myeloid, Acute | - | - |
Pancreatic Cancer
1 drug in this indication
Acute Myeloid Leukemia
1 drug in this indication
Leukemia, Myeloid, Acute
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in Aptose Biosciences Inc.'s drug pipeline?→
CatalystAlert tracks 3 drug candidates in Aptose Biosciences Inc.'s (APTOF) pipeline across Phase 3, Phase 2. Its lead program is Virulizin® (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Aptose Biosciences Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Aptose Biosciences Inc. (APTOF) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track APTOF biotech catalysts?→
Add APTOF to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Aptose Biosciences Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.